Ulrike Laß

864 total citations
20 papers, 453 citations indexed

About

Ulrike Laß is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Ulrike Laß has authored 20 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 10 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Ulrike Laß's work include Glioma Diagnosis and Treatment (8 papers), Epigenetics and DNA Methylation (5 papers) and Mesenchymal stem cell research (4 papers). Ulrike Laß is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Epigenetics and DNA Methylation (5 papers) and Mesenchymal stem cell research (4 papers). Ulrike Laß collaborates with scholars based in Germany, United States and Canada. Ulrike Laß's co-authors include Wolf Mueller, Andreas von Deimling, Christian Hartmann, M Reichenberger, Günter Germann, Uwe Leimer, Suzanne Kamel‐Reid, Martha Maria Gebhard, Christel Herold‐Mende and Javier S. Castresana and has published in prestigious journals such as PLoS ONE, Annals of Neurology and Clinical Cancer Research.

In The Last Decade

Ulrike Laß

19 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrike Laß Germany 13 218 213 115 79 63 20 453
Quynh Vu United States 10 249 1.1× 151 0.7× 59 0.5× 51 0.6× 27 0.4× 10 515
Woei-Cherng Shyu Taiwan 10 210 1.0× 194 0.9× 70 0.6× 90 1.1× 75 1.2× 13 494
Ana Paiva Portugal 14 114 0.5× 230 1.1× 91 0.8× 61 0.8× 129 2.0× 31 622
Adam Nowakowski Poland 12 325 1.5× 292 1.4× 61 0.5× 139 1.8× 50 0.8× 23 632
Daniele Porcelli Italy 6 138 0.6× 369 1.7× 121 1.1× 120 1.5× 170 2.7× 6 631
Yu-Hsun Chang Taiwan 6 293 1.3× 289 1.4× 132 1.1× 190 2.4× 36 0.6× 11 688
Valerie Eaton United States 7 318 1.5× 151 0.7× 65 0.6× 90 1.1× 66 1.0× 8 534
Claire Peghaire United Kingdom 13 104 0.5× 356 1.7× 72 0.6× 41 0.5× 55 0.9× 16 642
Karine Durand France 16 105 0.5× 212 1.0× 79 0.7× 85 1.1× 83 1.3× 26 537
Yuichi Ohki Japan 4 105 0.5× 227 1.1× 110 1.0× 62 0.8× 111 1.8× 5 484

Countries citing papers authored by Ulrike Laß

Since Specialization
Citations

This map shows the geographic impact of Ulrike Laß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Laß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Laß more than expected).

Fields of papers citing papers by Ulrike Laß

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Laß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Laß. The network helps show where Ulrike Laß may publish in the future.

Co-authorship network of co-authors of Ulrike Laß

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Laß. A scholar is included among the top collaborators of Ulrike Laß based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Laß. Ulrike Laß is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reichenberger, M, Wolf Mueller, Yannick Diehm, et al.. (2015). ADSCs in a fibrin matrix enhance nerve regeneration after epineural suturing in a rat model. Microsurgery. 36(6). 491–500. 34 indexed citations
2.
Reichenberger, M, Ulrike Laß, Günter Germann, et al.. (2013). Pulsed Acoustic Cellular Expression (PACE) Reduces Capsule Formation Around Silicone Implants. Aesthetic Plastic Surgery. 38(1). 244–251. 7 indexed citations
3.
Laß, Ulrike, Astrid Nümann, Kajetan von Eckardstein, et al.. (2012). Clonal Analysis in Recurrent Astrocytic, Oligoastrocytic and Oligodendroglial Tumors Implicates IDH1- Mutation as Common Tumor Initiating Event. PLoS ONE. 7(7). e41298–e41298. 42 indexed citations
4.
Mueller, Wolf, Ulrike Laß, Martha Maria Gebhard, et al.. (2012). Bed Isolation in Experimental Flap Studies in Rats. Annals of Plastic Surgery. 70(3). 354–359. 2 indexed citations
5.
Reichenberger, M, Ulrike Laß, Martha Maria Gebhard, et al.. (2012). Adipose Derived Stem Cells Protect Skin Flaps Against Ischemia-Reperfusion Injury. Stem Cell Reviews and Reports. 8(3). 854–862. 49 indexed citations
6.
Reichenberger, M, et al.. (2012). Fibrin-Embedded Adipose Derived Stem Cells Enhance Skin Flap Survival. Stem Cell Reviews and Reports. 8(3). 844–853. 17 indexed citations
7.
Laß, Ulrike, Christian Hartmann, David Capper, et al.. (2012). Chromogenic in situ Hybridization is a Reliable Alternative to Fluorescence in situ Hybridization for Diagnostic Testing of 1p and 19q Loss in Paraffin‐Embedded Gliomas. Brain Pathology. 23(3). 311–318. 22 indexed citations
8.
Reichenberger, M, Ulrike Laß, Martha Maria Gebhard, et al.. (2011). Extracorporeal shock wave treatment protects skin flaps against ischemia–reperfusion injury. Injury. 43(3). 374–380. 29 indexed citations
9.
Mueller, Wolf, Yael Spector, Tina Bocker Edmonston, et al.. (2011). Accurate Classification of Metastatic Brain Tumors Using a Novel MicroRNA-Based Test. The Oncologist. 16(2). 165–174. 23 indexed citations
10.
Siegelin, Markus D., et al.. (2009). Epigenetic Silencing of Death Receptor 4 Mediates Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance in Gliomas. Clinical Cancer Research. 15(17). 5457–5465. 41 indexed citations
12.
Truß, Matthias, Sven Wellmann, Ulrike Laß, et al.. (2007). Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death. Journal of Neuro-Oncology. 86(1). 23–30. 8 indexed citations
13.
Mueller, Wolf, Ulrike Laß, Vytenis Pranas Deltuva, et al.. (2007). Frequent epigenetic silencing of NPTXII and AREG in glioblastomas.
14.
Mueller, Wolf, et al.. (2005). Mutation analysis of DKK1 and in vivo evidence of predominant p53-independent DKK1 function in gliomas. Acta Neuropathologica. 109(3). 314–320. 9 indexed citations
15.
Hartmann, Christian, Wolf Mueller, Ulrike Laß, Suzanne Kamel‐Reid, & Andreas von Deimling. (2005). Molecular Genetic Analysis of Oligodendroglial Tumors. Journal of Neuropathology & Experimental Neurology. 64(1). 10–14. 44 indexed citations
16.
Posch, Maximilian, Chuanbing Zang, Wolf Mueller, et al.. (2004). Somatic mutations in peroxisome proliferator-activated receptor-gamma are rare events in human cancer cells.. PubMed. 10(8). BR250–4. 19 indexed citations
17.
Tallen, Gesche, Ulrike Laß, Christian Hartmann, et al.. (2004). No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytoma. International Journal of Cancer. 109(3). 476–479. 26 indexed citations
18.
Mueller, Wolf, Ulrike Laß, Werner Paulus, et al.. (2003). No evidence of hSNF5/INI1 point mutations in choroid plexus papilloma. Neuropathology and Applied Neurobiology. 30(3). 304–307. 10 indexed citations
19.
Hartmann, Christian, Wolf Mueller, Ulrike Laß, et al.. (2003). No preferential loss of paternal 19q alleles in oligodendroglial tumors. Annals of Neurology. 54(2). 256–258. 8 indexed citations
20.
Mueller, Wolf, Ulrike Laß, Jochen Herms, et al.. (2001). Clonal Analysis in Glioblastoma with Epithelial Differentiation. Brain Pathology. 11(1). 39–43. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026